Details of the Drug

General Information of Drug (ID: DMREGCT)

Drug Name

EP HIV-1090 vaccine

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Phase 1	[1]
Human immunodeficiency virus-1 infection	1C62	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00532974) A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART). U.S. National Institutes of Health.